Eli Lilly (Lilly) has agreed to make a $10m upfront payment for full worldwide rights to San Diego-based Organovo Holdings’ ...

Eli Lilly has acquired Organovo’s lead asset, a clinical FXR agonist designed to treat inflammatory bowel disease (IBD), in a ...

The deal with Lilly is a crucial boost for Organovo, which ended last year with just $1.2 million in cash and nearly $350 million in debt. Organovo FXR is a clinical drug program focused on farnesoid ...

Eli Lilly is buying Organovo’s farnesoid X receptor (FXR) agonist program, which includes a drug in Phase 2 development for ...

Holdings announced that Eli Lilly (LLY) and Company will acquire Organovo’s FXR program, including its lead asset, FXR314.

Organovo shares are trading higher by 246% Tuesday morning. The company announced that Eli Lilly is set to acquire its FXR ...

Eli Lilly (NYSE: LLY) stock defied today's market downturn, rising 2.6% through 11:15 a.m. ET on the back of two positive ...

OAK BLUFF, Manitoba, February 18, 2025--(BUSINESS WIRE)--FXR Pro Fish, a brand driven by bringing innovation to the water, is ...

PALATKA, Fla. (KLTV) - Longview native Lee Livesay placed 17th on the third day of the FXR Pro Fish Bassmaster Elite at St.

Organovo today announced that Eli Lilly and Company (NYSE:LLY) ("Lilly") will acquire Organovo's FXR program, including its ...

FXR Pro Fish has signed on as the title sponsor for the 2025 Bassmaster Elite at St. Johns River in Palatka, Florida. / Seigo Saito | B.A.S.S. “We are excited that FXR will be the title sponsor ...

The 2025 FXR Pro Fish Team Bassmaster Elite Will Hit The Water At St. Johns River FXR Pro Fish, a brand driven by bringing innovation to the water, is proud to announce its partnership with the ...